Skip to main content

Mireia Lopez Corbeto

I graduated in Medicine from the University of Barcelona and in 2017 I completed my training in Rheumatology at the Vall d'Hebron University Hospital. During my formative period I did a four month training stay at the University of Alabama and Children's Hospital at Birmingham (Alabama, United States) in Pediatric Rheumatology. At the end of the residency I combined care tasks at the Pediatric Rheumatology Unit with research, developing my PhD program in the framework of a study funded by the Carlos III Health Research Fund (FIS), focused on the study of Juvenile Idiopathic Arthritis and precision medicine. I recently completed a study placement at the HudsonAlpha Institute for Biotechnology (Alabama, USA) focused on computational biology and bioinformatics.   I continue my educational activity pursuing the Master's Degree in Research Methodology in Health Sciences of the Autonomous University of Barcelona, ​​and I participate in national and international courses, congresses and scientific conferences in the field of Pediatric Rheumatology. I take an active part in the spread of childhood rheumatic diseases in training courses for professionals and workshops for families.

Institutions of which they are part

Main researcher
Rheumatology
Vall Hebron Institut de Recerca
Doctor
Rheumatology
Traumatology, Rehabilitation and Burns Hospital

Mireia Lopez Corbeto

Institutions of which they are part

Main researcher
Rheumatology
Vall Hebron Institut de Recerca
Doctor
Rheumatology
Traumatology, Rehabilitation and Burns Hospital

I graduated in Medicine from the University of Barcelona and in 2017 I completed my training in Rheumatology at the Vall d'Hebron University Hospital. During my formative period I did a four month training stay at the University of Alabama and Children's Hospital at Birmingham (Alabama, United States) in Pediatric Rheumatology. At the end of the residency I combined care tasks at the Pediatric Rheumatology Unit with research, developing my PhD program in the framework of a study funded by the Carlos III Health Research Fund (FIS), focused on the study of Juvenile Idiopathic Arthritis and precision medicine. I recently completed a study placement at the HudsonAlpha Institute for Biotechnology (Alabama, USA) focused on computational biology and bioinformatics.   I continue my educational activity pursuing the Master's Degree in Research Methodology in Health Sciences of the Autonomous University of Barcelona, ​​and I participate in national and international courses, congresses and scientific conferences in the field of Pediatric Rheumatology. I take an active part in the spread of childhood rheumatic diseases in training courses for professionals and workshops for families.

I am an assistant doctor in the Rheumatology service and I develop my medical activity in the Pediatric Rheumatology and Rheumatology unit of the young adult. The Unit offers a comprehensive follow-up of pediatric patients through outpatient clinics and evaluation of patients admitted with pediatric rheumatic pathology. We also evaluate pediatric musculoskeletal pathology with joint ultrasound and diagnostic-therapeutic tests such as arthrocentesis and joint infiltration.

Projects

Caracterización por single cell RNA-seq de las células T patogénicas en la artritis idiopática juvenil oliogarticular, estudio de aplicabilidad translacional.

IP: Mireia Lopez Corbeto
Collaborators: -
Funding agency: Sociedad Española de Reumatología Pediátrica SERP
Funding: 8000
Reference: SERPE/REUMAPED/2022/LOPEZ
Duration: 30/12/2022 - 29/12/2024

ESTUDI DE SEGURETAT I IMMUNOGENICITAT VACUNAL EN PACIENTS PEDIÀTRICS AMB MALALTIES REUMÀTIQUES

IP: Mireia Lopez Corbeto
Collaborators: -
Funding agency: Stat Catalana Reumatologia – ACMSCB
Funding: 6000
Reference: SCR/BECAABBIE/2020/LOPEZ
Duration: 01/01/2020 - 31/03/2021

Caracterización de RNA-seq de células individuales de células T CD4 + patológicas en artritis idiopática juvenil oligoarticular y estudio de aplicabilidad traslacional

IP: Sara Marsal Barril
Collaborators: Nuria Palau Balaña, Luis Riera Soler, Estefania Moreno Ruzafa, Mireia Lopez Corbeto, Adria Aterido Ballonga
Funding agency: Instituto de Salud Carlos III
Funding: 208120
Reference: PI19/00225
Duration: 01/01/2020 - 30/06/2024

Estudio de las enfermedades inflamatorias mediadas por inmunidad (Immuno-mediated Inflammatory Diseases, IMIDs) en el marco de la Medicina de Precisión.

IP: Sara Marsal Barril
Collaborators: Mireia Lopez Corbeto, Laia Perez Lasarte
Funding agency: Instituto de Salud Carlos III
Funding: 53732
Reference: CM18/00012
Duration: 01/01/2019 - 09/01/2022

Related news

The head of the Rheumatology Service at Vall d'Hebron University Hospital and of the Rheumatology research group at VHIR is a highly accomplished rheumatologist with a distinguished career in the field.

It is the first international multi-centre clinical trial to analyse the safety and effect of this treatment for an autoimmune disease.

Els estudis avançaran en els camps de les malalties digestives, el VIH, la fatiga crònica, les patologies cardíaques, l’hepatitis, la diabetis i l’oftalmologia.

Related professionals

Anna  Abuli  Vidal

Anna Abuli Vidal

Postdoctoral researcher
Genetics Medicine
Read more
Jorge Aguilera Sáez

Jorge Aguilera Sáez

Read more
Isabel Claveria Guiu

Isabel Claveria Guiu

Infectious Diseases
Read more
Felipe Hernando Bartolome

Felipe Hernando Bartolome

Molecular Medical Imaging
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.